Log In
Print
BCIQ
Print
Print this Print this
 

Irtra, Irbesartan/trichloromethiazide (S-474474)

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionCombination of a small molecule angiotensin II receptor antagonist and a thiazidal antihypertensive diuretic
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

Japan - Standard Review (Treat hypertension)

Partner

Sanofi


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today